Skip to main content

CITADEL ADVISORS LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1423053 MIAMI, FL

Position in KPTI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$233,378 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Derivatives in KPTI

reported options exposure · as of Mar 31, 2026
CallValue
$1,388,601
CallShares
249,300
PutValue
$1,438,174
PutShares
258,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in KPTI

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,438,174 258,200
2026-03-31 $1,388,601 249,300
2025-12-31 $233,378 31,709
2025-12-31 $524,768 71,300
2025-12-31 $239,200 32,500
2025-09-30 $302,802 46,300
2025-09-30 $298,878 45,700
2025-06-30 $69,925 16,224
2025-06-30 $891,225 206,781
2025-03-31 $40,384 10,798
2025-03-31 $13,381 3,578
2025-03-31 $773,838 206,909